You are here: Home: PCU Think Tank 1 | 2006: Faculty Disclosures

FACULTY AFFILIATIONS

Gerald W Chodak, MD Director, Midwest Prostate and Urology Health Center The University of Chicago Chicago, Illinois E David Crawford, MD Professor of Surgery and Radiation Oncology Head, Urologic Oncology University of Colorado Health Sciences Center Aurora, Colorado Mario A Eisenberger, MD R Dale Hughes Professor of Oncology and Urology The Johns Hopkins University Baltimore, Maryland Stephen J Freedland, MD Attending Physician Durham VA Medical Center Assistant Professor of Urology and Pathology Duke University School of Medicine Durham, North Carolina

Leonard G Gomella, MD The Bernard W Godwin Professor of Prostate Cancer Chairman, Department of Urology Jefferson Medical College Director of Urologic Oncology Kimmel Cancer Center Philadelphia, Pennsylvania Thomas E Keane, MBBCh Chairman and Professor Medical University of South Carolina Department of Urology Charleston, South Carolina Laurence Klotz, MD Professor of Surgery University of Toronto Chief, Division of Urology Sunnybrook and Women’s College Health Sciences Center Toronto, Ontario Daniel P Petrylak, MD Associate Professor of Medicine Director, Genitourinary Oncology Program, Columbia Presbyterian Medical Center New York, New York

Paul F Schellhammer, MD Professor, Eastern Virginia Medical School Norfolk, Virginia Howard I Scher, MD D Wayne Calloway Chair in Urologic Oncology Chief, Genitourinary Oncology Service Memorial Sloan-Kettering Cancer Center New York, New York Michael J Zelefsky, MD Chief, Brachytherapy Service Memorial Sloan-Kettering Cancer Center New York, New York Craig D Zippe, MD Co-Director, Prostate Center Glickman Urological Institute The Cleveland Clinic Foundation Cleveland, Ohio

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech Inc/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Chodak — Speakers Bureau: Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation, Threshold Pharmaceuticals. Dr Crawford — Consulting Fees and Speakers Bureau: Auxilium Pharmaceuticals Inc, GlaxoSmithKline, Sanofi-Aventis. Dr Eisenberger — Consulting Fees: Amgen Inc, ImClone Systems, Merck and Company Inc, Sanofi-Aventis; Contracted Research: Celgene Corporation, Centocor Inc, Cytogen Corporation, Prostate Cancer Foundation, Sanofi-Aventis. Dr Freedland — Consulting Fees: AstraZeneca Pharmaceuticals LP; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP. Dr Gomella — Consulting Fees: GlaxoSmithKline; Speakers Bureau: AstraZeneca Pharmaceuticals LP, TAP Pharmaceuticals Inc. Dr Keane — Consulting Fees: AstraZeneca Pharmaceuticals LP, Auxilium Pharmaceuticals Inc, Sanofi-Aventis, Valera Pharmaceuticals; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Auxilium Pharmaceuticals Inc, Cytogen Corporation, Pfizer Inc. Dr Klotz — Consulting Fees: Abbott Laboratories, AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Merck and Company Inc, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Abbott Laboratories, AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Merck and Company Inc, Sanofi-Aventis. Dr Petrylak — Consulting Fees: Abbott Laboratories, Bristol-Myers Squibb Company, Celgene Corporation, Cell Genesys Inc, Centocor Inc, Dendreon Corporation, Eli Lilly and Company, GPC Biotech Inc, Novartis Pharmaceuticals Corporation, Roche Laboratories Inc, Sanofi- Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Sanofi-Aventis; Contracted Research: Abbott Laboratories, Cell Genesys Inc, Eli Lilly and Company, GPC Biotech Inc, Sanofi- Aventis. Dr Schellhammer — Consulting Fees: Dendreon Corporation, Sanofi-Aventis; Contracted Research: AstraZeneca Pharmaceuticals LP, Sanofi-Aventis; Ownership Interest: Dendreon Corporation. Dr Scher — Contracted Research: AstraZeneca Pharmaceuticals LP, Sanofi-Aventis. Dr Zelefsky — Consulting Fees: Oncura, Varian Inc. Dr Zippe — Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Pfizer Inc.

Home